Agree 100%. Unfortunately, the big pharmas with deep pockets keep this scam going to the detriment of those suffering from Alzheimer's Disease. Finding favor now that in a sub-group of patients on BIIB's AD drug, only 35% experience brain swelling, down from 55%, is mind boggling. Anavex 2-73 is the best hope for AD sufferers. Maybe AF will have an epiphany and publish an upbeat piece on the results of Anavex Clinical Trial. Wouldn't that level the playing field?